Cash Flow Aceso Life Science Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-933.00
-498.00
-4.00
-481.00
-611.00
-318.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-16.00
-107.00
566.00
346.00
92.00
-228.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-63.00
-200.00
545.00
312.00
120.00
-338.00
Cash Flow from Investing Activities
311.00
472.00
34.00
-480.00
-10.00
930.00
Cash Flow from Financing Activities
-499.00
-161.00
-141.00
301.00
-262.00
-307.00
Net Cash Inflow / Outflow
-236.00
119.00
426.00
129.00
-140.00
283.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
15.00
8.00
-12.00
-4.00
12.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Aceso Life Science Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-933.000000003726
-88.366
-845.00
-955.84%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-16.0000000000639
17.374
-33.00
-192.09%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-63.0000000002516
-2.616
-61.00
-2308.26%
Cash Flow from Investing Activities
311.000000001242
16.768
295.00
1754.72%
Cash Flow from Financing Activities
-499.000000001993
15.743
-514.00
-3269.66%
Net Cash Inflow / Outflow
-236.000000000942
30.505
-266.00
-873.64%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
15.0000000000599
0.61
15.00
2359.02%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 68.50% vs -136.70% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
-63.00
-200.00
68.50%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
